Robert Lechleider
Chief Medical Officer at Immunome Inc. (IMNM)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 7SEC | IMNMImmunome Inc. | Sell Plan | 22,71448,091 held (−32%) | $21.95 | $499K | -10.9% |
| Jul 7SEC | IMNMImmunome Inc. | Sell Plan | 16,21431,877 held (−34%) | $22.76 | $369K | -14.1% |
| Jul 7SEC | IMNMImmunome Inc. | Sell Plan | 16,07215,805 held (−50%) | $23.44 | $377K | -16.6% |
| Jun 29SEC | IMNMImmunome Inc. | Sell Plan | 40,58030,225 held (−57%) | $19.56 | $794K | -0.1% |
| Jun 29SEC | IMNMImmunome Inc. | Sell Plan | 14,42015,805 held (−48%) | $20.66 | $298K | -5.4% |
- Sell
Chief Medical Officer Robert Lechleider sold $499K of IMNM at $21.95 — cuts the stake by 32%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Robert Lechleider sold $369K of IMNM at $22.76 — cuts the stake by 34%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Robert Lechleider sold $377K of IMNM at $23.44 — cuts the stake by 50%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Robert Lechleider sold $794K of IMNM at $19.56 — cuts the stake by 57%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Robert Lechleider sold $298K of IMNM at $20.66 — cuts the stake by 48%; pre-scheduled 10b5-1 plan sale.